Huang WC et al. |
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. |
2002 |
Exp. Cell Res. |
pmid:12083801
|
Mantel A et al. |
Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. |
2014 |
Exp. Dermatol. |
pmid:24917395
|
Jeon KI et al. |
Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts. |
2015 |
Exp. Eye Res. |
pmid:26142957
|
Kuriyan AE et al. |
Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. |
2012 |
Exp. Eye Res. |
pmid:22178289
|
Nencioni A et al. |
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. |
2002 |
Exp. Hematol. |
pmid:12225793
|
Kanbe E et al. |
DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand. |
2003 |
Exp. Hematol. |
pmid:12691917
|
Kim BE et al. |
Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. |
2003 |
Exp. Mol. Med. |
pmid:14508070
|
Lee KJ et al. |
Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. |
2004 |
Exp. Mol. Med. |
pmid:15665586
|
Kim HJ et al. |
15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. |
2005 |
Exp. Mol. Med. |
pmid:16000871
|
Zhang HX et al. |
Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2). |
2010 |
Exp. Neurol. |
pmid:20083106
|
Muñoz U et al. |
The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients. |
2005 |
Exp. Neurol. |
pmid:16061222
|
Lotz C et al. |
Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. |
2011 |
Exp. Physiol. |
pmid:21123361
|
Okada M et al. |
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. |
2002 |
FASEB J. |
pmid:12468449
|
Wayman NS et al. |
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. |
2002 |
FASEB J. |
pmid:12087064
|
Kalantari P et al. |
15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. |
2009 |
FASEB J. |
pmid:19299483
|
Planagumà A et al. |
The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. |
2005 |
FASEB J. |
pmid:15876570
|
Gilroy DW et al. |
Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. |
2003 |
FASEB J. |
pmid:14563690
|
Zernecke A et al. |
Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. |
2003 |
FASEB J. |
pmid:12692090
|
Coyle AT et al. |
15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. |
2005 |
FEBS J. |
pmid:16156795
|
Mazid MA et al. |
Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. |
2006 |
FEBS Lett. |
pmid:17150216
|
Antoun J et al. |
CYP4A11 is repressed by retinoic acid in human liver cells. |
2006 |
FEBS Lett. |
pmid:16712844
|
Faveeuw C et al. |
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. |
2000 |
FEBS Lett. |
pmid:11119715
|
Gayarre J et al. |
Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. |
2005 |
FEBS Lett. |
pmid:16223487
|
Na HK et al. |
ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells. |
2005 |
FEBS Lett. |
pmid:16253239
|
Sugiyama H et al. |
Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. |
2000 |
FEBS Lett. |
pmid:10675550
|
Waku T et al. |
Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands. |
2009 |
FEBS Lett. |
pmid:19101554
|
Boyault S et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. |
2004 |
FEBS Lett. |
pmid:15304320
|
Hong HY et al. |
Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. |
2008 |
FEBS Lett. |
pmid:18291107
|
Boyault S et al. |
15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. |
2001 |
FEBS Lett. |
pmid:11457450
|
Pritts EA et al. |
Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. |
2003 |
Fertil. Steril. |
pmid:12909507
|
Wanichkul T et al. |
Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. |
2003 |
Fertil. Steril. |
pmid:12620489
|
Kim YS et al. |
Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. |
2005 |
Free Radic. Biol. Med. |
pmid:15589375
|
Cerbone A et al. |
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. |
2007 |
Free Radic. Biol. Med. |
pmid:17462534
|
Higdon AN et al. |
Methods for imaging and detecting modification of proteins by reactive lipid species. |
2009 |
Free Radic. Biol. Med. |
pmid:19446632
|
Brechbuhl HM et al. |
Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport. |
2009 |
Free Radic. Biol. Med. |
pmid:19520157
|
Lee E et al. |
15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes. |
2012 |
Free Radic. Biol. Med. |
pmid:22245093
|
Kansanen E et al. |
Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2. |
2009 |
Free Radic. Biol. Med. |
pmid:19573595
|
Lin YC et al. |
The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚-treated endothelial cells. |
2012 |
Free Radic. Biol. Med. |
pmid:22387200
|
Kang ES et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells. |
2014 |
Free Radic. Res. |
pmid:24180671
|
Li L et al. |
Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. |
2003 |
Gastroenterology |
pmid:12891549
|
Marra F et al. |
Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. |
2000 |
Gastroenterology |
pmid:10930382
|
Ponferrada A et al. |
The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. |
2007 |
Gastroenterology |
pmid:17484875
|
Matzkin ME et al. |
Exploring the cyclooxygenase 2 (COX2)/15d-Δ(12,14)PGJ(2) system in hamster Sertoli cells: regulation by FSH/testosterone and relevance to glucose uptake. |
2012 |
Gen. Comp. Endocrinol. |
pmid:22974512
|
Tsujita T et al. |
Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. |
2011 |
Genes Cells |
pmid:21143560
|
Kobayashi M et al. |
ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. |
2006 |
Genes Cells |
pmid:16824197
|
Urahama N et al. |
The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation. |
2005 |
Genes Cells |
pmid:16324150
|
Natarajan C and Bright JJ |
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. |
2002 |
Genes Immun. |
pmid:11960303
|
Li XY et al. |
15-Deoxy-prostaglandin J2 anti-inflammation in a rat model of chronic obstructive pulmonary disease and human bronchial epithelial cells via Nrf2 activation. |
2015 |
Genet. Mol. Res. |
pmid:26535717
|
Kerr BJ et al. |
The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. |
2008 |
Glia |
pmid:18205174
|
Shimada T et al. |
Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. |
2002 |
Gut |
pmid:11950812
|
Leung WK et al. |
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. |
2004 |
Gut |
pmid:14960510
|
Yuan Z et al. |
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. |
2005 |
Heart |
pmid:15774612
|
Galli A et al. |
Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. |
2000 |
Hepatology |
pmid:10613734
|
Copple IM et al. |
The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. |
2008 |
Hepatology |
pmid:18785192
|
Kuboki S et al. |
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. |
2008 |
Hepatology |
pmid:18085707
|
Mendez M and LaPointe MC |
PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. |
2003 |
Hypertension |
pmid:12885795
|
Katsumata Y et al. |
Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. |
2014 |
Hypertension |
pmid:24101662
|
Ikeda U et al. |
Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. |
2000 |
Hypertension |
pmid:10856269
|
Kim HY and Kim HS |
Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. |
2007 |
Immunol. Cell Biol. |
pmid:17130903
|
Imaizumi T et al. |
15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. |
2002 |
Immunol. Cell Biol. |
pmid:12406386
|
Kim HY et al. |
Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. |
2005 |
Immunol. Cell Biol. |
pmid:15877607
|
Harris SG and Phipps RP |
Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. |
2002 |
Immunology |
pmid:11849312
|
Sykes L et al. |
The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour. |
2013 |
Immunology |
pmid:23374103
|
Han S and Sidell N |
Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. |
2002 |
Immunology |
pmid:11972632
|
Arnold R et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. |
2007 |
Immunology |
pmid:17425601
|
Miyawaki T et al. |
Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells. |
2012 |
Immunopharmacol Immunotoxicol |
pmid:21854184
|
Sánchez-Gómez FJ et al. |
Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs. |
2013 |
Inflamm Allergy Drug Targets |
pmid:23596995
|
MartÃnez AE et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner. |
2012 |
Inflamm Allergy Drug Targets |
pmid:22309084
|
Fernandez-Bustamante A et al. |
Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. |
2013 |
Inflammation |
pmid:23616184
|
Hashimoto K et al. |
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. |
2002 |
Int J Gastrointest Cancer |
pmid:12630765
|
Fujita M et al. |
Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma. |
2012 |
Int J Med Sci |
pmid:22991494
|
Abbasi S et al. |
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion. |
2016 |
Int J Nanomedicine |
pmid:27354798
|
Ueki S et al. |
Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. |
2007 |
Int. Arch. Allergy Immunol. |
pmid:17541271
|
Chiba T et al. |
15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292). |
2009 |
Int. Arch. Allergy Immunol. |
pmid:19494510
|
Imaizumi T et al. |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. |
2003 |
Int. Arch. Allergy Immunol. |
pmid:12759491
|
Zhang M et al. |
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. |
2006 |
Int. Immunopharmacol. |
pmid:16782535
|
Napimoga MH et al. |
Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. |
2013 |
Int. Immunopharmacol. |
pmid:23597428
|
Kanunfre CC et al. |
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. |
2004 |
Int. Immunopharmacol. |
pmid:15251113
|
Wu P et al. |
Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. |
2007 |
Int. Immunopharmacol. |
pmid:17761349
|
Chou YH et al. |
The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. |
2005 |
Int. J. Biochem. Cell Biol. |
pmid:15618017
|
Yu JH et al. |
SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. |
2008 |
Int. J. Biochem. Cell Biol. |
pmid:18035585
|
Winnett G et al. |
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. |
2003 |
Int. J. Cancer |
pmid:12494466
|
Badawi AF and Badr MZ |
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. |
2003 |
Int. J. Cancer |
pmid:12455057
|
Koyani CN et al. |
15-deoxy-Δ¹²,¹â´-PGJâ‚‚ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. |
2014 |
Int. J. Cardiol. |
pmid:24698234
|
Tsujimoto S et al. |
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. |
2016 |
Int. J. Mol. Med. |
pmid:27431935
|
Li H and Narahara H |
15-Deoxy-Δ(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines. |
2013 |
Int. J. Mol. Med. |
pmid:23403520
|
Da Silva Morais A et al. |
Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice. |
2007 |
Int. J. Mol. Med. |
pmid:17143554
|
Jung WK et al. |
The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. |
2014 |
Int. J. Mol. Med. |
pmid:24337644
|
Yoshimura R et al. |
The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. |
2003 |
Int. J. Mol. Med. |
pmid:14612958
|
Okano H et al. |
The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells. |
2003 |
Int. J. Mol. Med. |
pmid:14612959
|
Moriai M et al. |
Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. |
2009 |
Int. J. Oncol. |
pmid:19360348
|
Haslmayer P et al. |
The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. |
2002 |
Int. J. Oncol. |
pmid:12239635
|
Matsuzaki Y et al. |
15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. |
2005 |
Int. J. Oncol. |
pmid:16010433
|
Morosetti R et al. |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. |
2004 |
Int. J. Oncol. |
pmid:15254749
|
Shim J et al. |
The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. |
2010 |
Int. J. Oncol. |
pmid:19956851
|
Cekanova M et al. |
Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. |
2008 |
Int. J. Oncol. |
pmid:18360708
|
Takashima T et al. |
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. |
2001 |
Int. J. Oncol. |
pmid:11494023
|
Marshall JC |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? |
2005 |
Intensive Care Med |
pmid:15782317
|
Hauser B et al. |
Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. |
2006 |
Intensive Care Med |
pmid:16534570
|
Marzocco S et al. |
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. |
2005 |
Intensive Care Med |
pmid:15868139
|